Partnership Style
Shire Pharmaceuticals Partnership Credentials
Shire is a rapidly growing, successful speciality pharmaceutical company. To a large extent, this success has been built upon an effective approach to external partnerships at all levels.
Shire has built an impressive and balanced portfolio through a series of company, product and project collaborations and acquisitions.
To any prospective partner, Shire offers
- A highly experienced executive management team, that importantly, for a company of Shire’s size and growth, retains a flexible and creative approach to collaborations
- Experienced Sales and Marketing capability in the leading World markets, focused upon speciality pharmaceuticals
- Proven product development and regulatory capability
- Objective and rapid response to partnering opportunities
- Results driven culture
Business Development
Shire’s Management Team look to Business Development as a major component of Shire’s growth and consequently all collaborative opportunities are managed in a rapid and responsible manner. To facilitate this, Shire’s business development team benefit from direct access to internal expertise across the full range of product development functions from initial scientific evaluations through to full commercial projections.
Opportunities with a good fit to Shire’s interests move rapidly from this initial evaluation stage, through due diligence to transaction.
Shire’s BD team welcome approaches from organisations with products or projects that fit with our areas of interests.
Marketed Products
Marketed or approved products that fit Shire’s existing sales portfolio are of particular interest. Shire seeks products with growth potential and patent protection. All products should be capable of growth through promotion to specialists. Shire offers established Speciality Sales and Marketing capability across the major North American and European markets and in other markets through existing distributors and licensees.
Drug Candidates
Shire seeks collaborative opportunities with organisations that have projects in development which match Shire’s strategic focus.
Shire’s specific in licensing interests are illustrated below
Phase 1 | Phase 2 | Phase 3 / | Marketed | |
CNS |  | | | |
Renal | | | | |
GI | | | | |
HGT | | | | |
Other Specialty Pharmaceuticals | | | | |
Orphan Drugs | | | | |
Did you know...
We have developed a
version of this web site
that is suitable for your
portable device.
